Table of Contents

Indications for Implantable Cardioverter-Defibrillator (ICD) Therapy

An Implantable Cardioverter-Defibrillator (ICD) is used to prevent sudden cardiac death by treating life-threatening ventricular arrhythmias such as ventricular tachycardia (VT) and ventricular fibrillation (VF).

ICDs may also provide backup pacing, anti-tachycardia pacing (ATP), and cardioversion/defibrillation shocks.

The American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) publish guideline-based recommendations for ICD implantation.

Primary Reference: 2017 ACC/AHA/HRS Guideline for Management of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death

Purpose of an ICD

ICDs are used for:

Indications fall into two broad categories:


I. Secondary Prevention ICD Indications

ICD implantation is Class I (definite) for patients who have survived:

These patients have a high risk of recurrent life-threatening arrhythmias.


II. Primary Prevention ICD Indications

Primary prevention aims to stop sudden cardiac death before the first arrhythmic event.

A. Ischemic Cardiomyopathy

Class I (recommended):

Class I (recommended):

B. Non-Ischemic Cardiomyopathy

Class I (recommended):

C. Genetic and Structural Heart Diseases

Class I (recommended):

Reference: ESC Guidelines – Sudden Cardiac Death


III. ICD After Cardiac Procedures or Acute Events

ICD may be indicated after:

ICD is not indicated if the arrhythmia is due to:


IV. Contraindications (Class III – NOT Indicated)

ICD implantation is not appropriate when:


V. Summary Table: ICD Indications

Condition Indication Class
VF arrest not from reversible cause ICD recommended Class I
Sustained VT with hemodynamic compromise ICD recommended Class I
Spontaneous sustained VT (stable or unstable) ICD recommended Class I
Post-MI LVEF ≤35% (NYHA II–III, ≥40 days post-MI) ICD recommended Class I
Post-MI LVEF ≤30% (NYHA I, ≥40 days post-MI) ICD recommended Class I
Non-ischemic cardiomyopathy LVEF ≤35% (NYHA II–III) ICD recommended Class I
Hypertrophic cardiomyopathy w/ high-risk features ICD recommended Class I
Long QT syndrome with syncope/VT ICD recommended Class I
Brugada syndrome with syncope/VT ICD recommended Class I
ARVC with sustained VT or severe dysfunction ICD recommended Class I
Reversible arrhythmias (drugs, electrolytes) ICD not indicated Class III
Severe comorbid illness with life expectancy <1 yr ICD not indicated Class III

Key Takeaways